menu close
neuron23.com
Neuron23 Inc-Logo

Neuron23 Stock

Company Profile:

Neuron23 is an early stage biotechnology company focused on developing personalized medicines for genetic disorders. Their mission is to create revolutionary treatments and future cures through advances in genetic research and our AI-enabled drug development platform.

Sign up for SecondMarket™ to view the market and buy or sell Neuron23 Stock
Buy + Sell
Leverage Your Equity to Help Achieve More.

Neuron23 Management Team

  • Director

    Michael Almstetter

  • CEO, Director

    Nancy Stagliano

  • Director

    Jim Scopa

  • Director

    Kevin Raidy

  • Director

    Vali Barsan

  • Founder, Chief Business Officer

    Adam Knight

  • Director

    Amrit Nagpal

Neuron23 Major Investors

  • Kleiner Perkins Caufield & Byers LLC (KPCB)

  • Surveyor Capital - Citadel

  • Westlake Village BioPartners

  • Cowen Healthcare Investments

  • Acorn Bioventures

  • HBM Partners AG

  • Redmile Group

  • Softbank Vision Fund 2

  • Perceptive Advisors, LLC

Learn More About Neuron23 Stock

Buy Neuron23 Stock
01

Neuron23 stock does not trade on public stock exchanges. Neuron23 stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Neuron23 stock you can either buy shares directly through company or work with a secondary trading marketplace like Nasdaq Private Market.

Learn more about the secondary market for private company shares on the investors page.

Sell Neuron23 Stock
02

Neuron23 Stock does not trade on public stock exchanges. In order to sell Neuron23 shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.

Learn more about NPM services for selling privately held stock on the Employee Shareholders page.

Read more about how to sell private company stock on the private secondary market:

Neuron23 Stock Price
03

Neuron23 does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Neuron23 share price and other valuable private market data.

Read more about secondary market private company stock prices:

Neuron23 Stock Ticker Symbol
04

There is no ticker symbol for Neuron23 stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.

Criteria to Sell Neuron23 Stock
05

Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Neuron23 stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.

Learn more about selling privately held stock on the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

Criteria to Buy or Invest in Neuron23 Stock
06

Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Neuron23 stock, you need to be an accredited entity or institutional investor.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

Neuron23 Stock Settlement
07

Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

Neuron23 IPO
08

Neuron23 is a private company and has not had an IPO. There is currently no Neuron23 IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Neuron23 IPO.

Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.

Sign up for SecondMarket™ to view the market and buy or sell Neuron23 Stock
Buy + Sell

*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.

Other Companies

Roman Health Ventures-Logo

Ro

Healthcare technology for a patient-centric healthcare system.

Insitro-Logo

insitro

Drug discovery and development company.

Eikon Therapeutics Inc-Logo

Eikon Therapeutics

A new biopharmaceutical company using revolutionary technology to discover novel treatments for life-threatening diseases.

Indigoag-Logo

Indigo Agriculture

Improves grower profitability, environmental sustainability, and consumer health through the use of natural microbiology and digital technologies.

Weareresilience-Logo

Resilience

Operates as technology-focused biomanufacturing company dedicated to broadening access to complex medicines.

Virta Health-Logo

Virta Health

Online specialty medical clinic focused on reversing type 2 diabetes.

Geltor

Animal-free, category-defining ingredients.

TurtleTree

Biotech company focused on creating sustainable and innovative nutrition solutions.

NewLimit-Logo

NewLimit

Develops epigenetic reprogramming therapies.

Source: Nasdaq Private Market Tape D™